PubMed Health⌕ Search

PubMed · 10118929

Antitrust issues for medical groups.

Abstract

Many medical groups may not regularly seek legal advice in regard to all the various business transactions in which they participate. Unlike hospitals, medical groups do not usually retain specialized health care law firms. As this professional paper illustrates, it is important for medical group administrators to have some familiarity with antitrust issues. This knowledge is important for administrators in two contexts: First, to keep their own groups from having antitrust problems; and second, to keep a watch on their competitors to be sure that the group's position is not compromised by any illegal activities engaged in by these entities.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F Gamma. 1992. Antitrust issues for medical groups.. https://pubmed.ncbi.nlm.nih.gov/10118929/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

State action antitrust immunity for public hospitals: it depends on what you mean by "foreseeable".

The Supreme Court's refusal to hear an appeal from the Fifth Circuit's ruling on the application of state action antitrust immunity doctrine leaves a split in the circuits as to the proper test to apply to determine antitrust immunity for public hospitals. The circuits have either adopted a "foreseeable conduct from state policy" approach or a "policy from foreseeable conduct" approach. This Article analyzes the approaches and demonstrates that the "foreseeable conduct from state policy" approach is the better of the two methods.

Antitrust Laws↗